- Home
- KOSS vs MAIA Comparison
KOSS vs MAIA Comparison
Compare KOSS & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- MAIA
- Stock Information
- Founded
- KOSS 1953
- MAIA 2018
- Country
- KOSS United States
- MAIA United States
- Employees
- KOSS N/A
- MAIA N/A
- Industry
- KOSS Consumer Electronics/Appliances
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- MAIA Health Care
- Exchange
- KOSS Nasdaq
- MAIA Nasdaq
- Market Cap
- KOSS 53.6M
- MAIA 56.7M
- IPO Year
- KOSS N/A
- MAIA 2022
- Fundamental
- Price
- KOSS $5.13
- MAIA $1.31
- Analyst Decision
- KOSS
- MAIA
- Analyst Count
- KOSS 0
- MAIA 0
- Target Price
- KOSS N/A
- MAIA N/A
- AVG Volume (30 Days)
- KOSS 42.7K
- MAIA 590.3K
- Earning Date
- KOSS 10-28-2025
- MAIA 11-11-2025
- Dividend Yield
- KOSS N/A
- MAIA N/A
- EPS Growth
- KOSS N/A
- MAIA N/A
- EPS
- KOSS N/A
- MAIA N/A
- Revenue
- KOSS $12,624,170.00
- MAIA N/A
- Revenue This Year
- KOSS N/A
- MAIA N/A
- Revenue Next Year
- KOSS N/A
- MAIA N/A
- P/E Ratio
- KOSS N/A
- MAIA N/A
- Revenue Growth
- KOSS 2.93
- MAIA N/A
- 52 Week Low
- KOSS $4.00
- MAIA $1.35
- 52 Week High
- KOSS $8.59
- MAIA $3.48
- Technical
- Relative Strength Index (RSI)
- KOSS 43.43
- MAIA 34.23
- Support Level
- KOSS $4.82
- MAIA $1.65
- Resistance Level
- KOSS $5.70
- MAIA $1.97
- Average True Range (ATR)
- KOSS 0.22
- MAIA 0.11
- MACD
- KOSS 0.03
- MAIA -0.04
- Stochastic Oscillator
- KOSS 34.94
- MAIA 1.46
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.